ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,283.36
-1.01%
Dow Jones
40,347.97
-1.21%
Gold vs US Dollar
2,442.44
-0.14%
Brent Oil
79.995
-1.86%
Bitcoin
64,111.29
-0.76%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
01/08/202421:43PR Newswire (US)Curbio Lands Spot on Inc. Magazine's Prestigious Inc. 5000 Regionals: Mid-Atlantic List
01/08/202421:42PR Newswire (US)CON EDISON REPORTS 2024 SECOND QUARTER EARNINGSNYSE:EDConsolidated Edison Inc
01/08/202421:37PR Newswire (US)MasTec Announces Second Quarter 2024 Financial Results and Updates Guidance for the YearNYSE:MTZMasTec Inc
01/08/202421:35PR Newswire (US)AES Reports Record Sales with Data Center HyperscalersNYSE:AESAES Corp
01/08/202421:33PR Newswire (US)Fairwater, the Newest Jones Act Energy and Chemical Transportation Provider, Formally Launches
01/08/202421:30UK RegulatoryLa FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLATG:ZVACellectis Nom Eo 05
01/08/202421:30UK RegulatoryFDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL TreatmentEU:ALCLSCellectis Nom Eo 05
01/08/202421:30UK RegulatoryLa FDA accorde le statut de médicament orphelin à CLLS52 (alemtuzumab) de Cellectis pour le traitement de la LLAEU:ALCLSCellectis Nom Eo 05
01/08/202421:30UK RegulatoryFDA Grants Orphan Drug Designation to Cellectis’ CLLS52 (alemtuzumab) For ALL TreatmentTG:ZVACellectis Nom Eo 05
01/08/202421:30PR Newswire (US)Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per ShareNASDAQ:SHBIShore Bancshares Inc
01/08/202421:30PR Newswire (US)Xenia Hotels & Resorts Reports Second Quarter 2024 ResultsNYSE:XHRXenia Hotels and Resorts Inc
01/08/202421:30PR Newswire (US)Ameren Announces Second Quarter 2024 ResultsNYSE:AEEAmeren Corp
01/08/202421:30PR Newswire (US)Inman Celebrates with the Real Estate Community by Announcing the Winners of the 2024 Inman Innovator Awards and the 2024 Golden I Awards
01/08/202421:30PR Newswire (US)Scripps promotes Detroit station sales leader to VP and general manager of KTNV in Las VegasNASDAQ:SSPEW Scripps Company
01/08/202421:30PR Newswire (US)Uranium Royalty Corp. Completes Acquisition of Additional Royalty on the Churchrock Uranium Project, New Mexico, USATSX:URCUranium Royalty Corp
01/08/202421:30PR Newswire (US)ONEOK Issues Annual Corporate Sustainability ReportNYSE:OKEONEOK Inc
01/08/202421:30PR Newswire (US)Servotronics Announces Death of Board Member Edward C. CosgroveAMEX:SVTServotronics Inc
01/08/202421:30PR Newswire (US)Uranium Royalty Corp. Completes Acquisition of Additional Royalty on the Churchrock Uranium Project, New Mexico, USANASDAQ:UROYUranium Royalty Corporation
01/08/202421:30PR Newswire (US)Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2024 and Cash DividendNYSE:SEMSelect Medical Holdings Corporation
01/08/202421:27PR Newswire (US)Construction Starts on Gateway Fiber's New Network in Brooklyn Park, MN
01/08/202421:27PR Newswire (US)JOHN HANCOCK CLOSED-END FUNDS DECLARE MONTHLY DISTRIBUTIONS
01/08/202421:22PR Newswire (US)Royce Global Financial Services Fund to Close
01/08/202421:20PR Newswire (US)First Industrial Realty Trust Declares Common Stock DividendsNYSE:FRFirst Industrial Realty Trust Inc
01/08/202421:20PR Newswire (US)Sunbelt Solomon Announces Acquisition of Maxima Power Group
01/08/202421:17PR Newswire (US)Heartland Dental and Concorde Career Colleges Announce Groundbreaking Partnership to Develop Co-Branded CampusNYSE:UTIUniversal Technical Institute Inc
01/08/202421:15PR Newswire (US)Graphic Packaging Holding Company Declares Quarterly DividendNYSE:GPKGraphic Packaging Holding Company
01/08/202421:15PR Newswire (US)Tronox Reports Second Quarter 2024 Financial ResultsNYSE:TROXTronox Holdings plc
01/08/202421:15PR Newswire (US)Cohen & Steers, Inc. Declares Quarterly DividendNYSE:CNSCohen and Steers Inc
01/08/202421:15PR Newswire (US)EOG Resources Reports Second Quarter 2024 ResultsNYSE:EOGEOG Resources Inc
01/08/202421:15PR Newswire (US)Paramount Global Declares Quarterly Cash DividendNASDAQ:PARAParamount Global

Your Recent History

LSE
GDR
Genedrive
LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
MTRO
Metro Bank
LSE
UKOG
Uk Oil & Gas
LSE
SOLG
Solgold
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
GKP
Gulf Keystone Petroleum
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
RR.
Rolls-royce
LSE
GWMO
Great Western Mining
LSE
KRS
Keras Resources
LSE
CYAN
Cyanconnode
LSE
TXP
Touchstone Exploration
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved